Neovasc to Present at Deutsche Bank Health Care Conference
VANCOUVER, May 4, 2015 /CNW/ – Neovasc Inc. (“Neovasc” or the “Company“) (NASDAQ: NVCN) (TSX: NVC) today announced that CFO Chris Clark is scheduled to present at the Deutsche Bank 40th Annual Health Care Conference on Wednesday, May 6, 2015, at 12:50 pm ET in Boston.
A live audio webcast of the presentation will be available on the Investors page of Neovasc’s website at www.neovasc.com.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products in development include Tiara™, for the transcatheter treatment of mitral valve disease and the Neovasc Reducer™ for the treatment of refractory angina. The Company also sells a line of advanced biological tissue products that are used as key components in third-party medical products including transcatheter heart valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.